Dapoxetine, marketed as Priligy, is a medication used for the treatment of premature ejaculation (PE) in men 18鈥�64 years old.听Dapoxetine听works by inhibiting the serotonin transporter, increasing serotonin's action at the post synaptic cleft, and as a consequence promoting ejaculatory delay.
The global Dapoxetine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dapoxetine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dapoxetine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Dapoxetine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Dapoxetine include Johnson & Johnson, Menarini, Hetero Healthcare, Sun Pharmaceuticals, Emcure Pharmaceuticals, Kelun Pharmaceutical, HUaPont Pharma, Hicin Pharmaceutical and Huiyinbi Group, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Dapoxetine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dapoxetine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dapoxetine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dapoxetine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dapoxetine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dapoxetine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Hetero Healthcare
Sun Pharmaceuticals
Emcure Pharmaceuticals
Kelun Pharmaceutical
HUaPont Pharma
Hicin Pharmaceutical
Huiyinbi Group
Sino Pharma
Kinhoo Pharmaceutical
Salubris
Lancom
Lianhuan Group
Northeast Pharmaceutical
Guangzhou Baiyunshan Pharma
Segment by Type
30 mg
60 mg
Segment by Application
Offline Channel
Online Channel
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dapoxetine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dapoxetine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dapoxetine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Dapoxetine Product Introduction
1.2 Market by Type
1.2.1 Global Dapoxetine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 30 mg
1.2.3 60 mg
1.3 Market by Application
1.3.1 Global Dapoxetine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Offline Channel
1.3.3 Online Channel
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dapoxetine Sales Estimates and Forecasts 2019-2030
2.2 Global Dapoxetine Revenue by Region
2.2.1 Global Dapoxetine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Dapoxetine Revenue by Region (2019-2024)
2.2.3 Global Dapoxetine Revenue by Region (2025-2030)
2.2.4 Global Dapoxetine Revenue Market Share by Region (2019-2030)
2.3 Global Dapoxetine Sales Estimates and Forecasts 2019-2030
2.4 Global Dapoxetine Sales by Region
2.4.1 Global Dapoxetine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Dapoxetine Sales by Region (2019-2024)
2.4.3 Global Dapoxetine Sales by Region (2025-2030)
2.4.4 Global Dapoxetine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dapoxetine Sales by Manufacturers
3.1.1 Global Dapoxetine Sales by Manufacturers (2019-2024)
3.1.2 Global Dapoxetine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dapoxetine in 2023
3.2 Global Dapoxetine Revenue by Manufacturers
3.2.1 Global Dapoxetine Revenue by Manufacturers (2019-2024)
3.2.2 Global Dapoxetine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dapoxetine Revenue in 2023
3.3 Global Key Players of Dapoxetine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Dapoxetine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dapoxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dapoxetine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dapoxetine, Product Offered and Application
3.8 Global Key Manufacturers of Dapoxetine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dapoxetine Sales by Type
4.1.1 Global Dapoxetine Historical Sales by Type (2019-2024)
4.1.2 Global Dapoxetine Forecasted Sales by Type (2025-2030)
4.1.3 Global Dapoxetine Sales Market Share by Type (2019-2030)
4.2 Global Dapoxetine Revenue by Type
4.2.1 Global Dapoxetine Historical Revenue by Type (2019-2024)
4.2.2 Global Dapoxetine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Dapoxetine Revenue Market Share by Type (2019-2030)
4.3 Global Dapoxetine Price by Type
4.3.1 Global Dapoxetine Price by Type (2019-2024)
4.3.2 Global Dapoxetine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Dapoxetine Sales by Application
5.1.1 Global Dapoxetine Historical Sales by Application (2019-2024)
5.1.2 Global Dapoxetine Forecasted Sales by Application (2025-2030)
5.1.3 Global Dapoxetine Sales Market Share by Application (2019-2030)
5.2 Global Dapoxetine Revenue by Application
5.2.1 Global Dapoxetine Historical Revenue by Application (2019-2024)
5.2.2 Global Dapoxetine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Dapoxetine Revenue Market Share by Application (2019-2030)
5.3 Global Dapoxetine Price by Application
5.3.1 Global Dapoxetine Price by Application (2019-2024)
5.3.2 Global Dapoxetine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Dapoxetine Market Size by Type
6.1.1 US & Canada Dapoxetine Sales by Type (2019-2030)
6.1.2 US & Canada Dapoxetine Revenue by Type (2019-2030)
6.2 US & Canada Dapoxetine Market Size by Application
6.2.1 US & Canada Dapoxetine Sales by Application (2019-2030)
6.2.2 US & Canada Dapoxetine Revenue by Application (2019-2030)
6.3 US & Canada Dapoxetine Market Size by Country
6.3.1 US & Canada Dapoxetine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Dapoxetine Sales by Country (2019-2030)
6.3.3 US & Canada Dapoxetine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dapoxetine Market Size by Type
7.1.1 Europe Dapoxetine Sales by Type (2019-2030)
7.1.2 Europe Dapoxetine Revenue by Type (2019-2030)
7.2 Europe Dapoxetine Market Size by Application
7.2.1 Europe Dapoxetine Sales by Application (2019-2030)
7.2.2 Europe Dapoxetine Revenue by Application (2019-2030)
7.3 Europe Dapoxetine Market Size by Country
7.3.1 Europe Dapoxetine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Dapoxetine Sales by Country (2019-2030)
7.3.3 Europe Dapoxetine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dapoxetine Market Size
8.1.1 China Dapoxetine Sales (2019-2030)
8.1.2 China Dapoxetine Revenue (2019-2030)
8.2 China Dapoxetine Market Size by Application
8.2.1 China Dapoxetine Sales by Application (2019-2030)
8.2.2 China Dapoxetine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dapoxetine Market Size by Type
9.1.1 Asia Dapoxetine Sales by Type (2019-2030)
9.1.2 Asia Dapoxetine Revenue by Type (2019-2030)
9.2 Asia Dapoxetine Market Size by Application
9.2.1 Asia Dapoxetine Sales by Application (2019-2030)
9.2.2 Asia Dapoxetine Revenue by Application (2019-2030)
9.3 Asia Dapoxetine Sales by Region
9.3.1 Asia Dapoxetine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Dapoxetine Revenue by Region (2019-2030)
9.3.3 Asia Dapoxetine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dapoxetine Market Size by Type
10.1.1 Middle East, Africa and Latin America Dapoxetine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Dapoxetine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Dapoxetine Market Size by Application
10.2.1 Middle East, Africa and Latin America Dapoxetine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Dapoxetine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Dapoxetine Sales by Country
10.3.1 Middle East, Africa and Latin America Dapoxetine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Dapoxetine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Dapoxetine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Johnson & Johnson Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Menarini
11.2.1 Menarini Company Information
11.2.2 Menarini Overview
11.2.3 Menarini Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Menarini Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Menarini Recent Developments
11.3 Hetero Healthcare
11.3.1 Hetero Healthcare Company Information
11.3.2 Hetero Healthcare Overview
11.3.3 Hetero Healthcare Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Hetero Healthcare Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hetero Healthcare Recent Developments
11.4 Sun Pharmaceuticals
11.4.1 Sun Pharmaceuticals Company Information
11.4.2 Sun Pharmaceuticals Overview
11.4.3 Sun Pharmaceuticals Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sun Pharmaceuticals Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceuticals Recent Developments
11.5 Emcure Pharmaceuticals
11.5.1 Emcure Pharmaceuticals Company Information
11.5.2 Emcure Pharmaceuticals Overview
11.5.3 Emcure Pharmaceuticals Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Emcure Pharmaceuticals Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Emcure Pharmaceuticals Recent Developments
11.6 Kelun Pharmaceutical
11.6.1 Kelun Pharmaceutical Company Information
11.6.2 Kelun Pharmaceutical Overview
11.6.3 Kelun Pharmaceutical Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Kelun Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kelun Pharmaceutical Recent Developments
11.7 HUaPont Pharma
11.7.1 HUaPont Pharma Company Information
11.7.2 HUaPont Pharma Overview
11.7.3 HUaPont Pharma Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 HUaPont Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 HUaPont Pharma Recent Developments
11.8 Hicin Pharmaceutical
11.8.1 Hicin Pharmaceutical Company Information
11.8.2 Hicin Pharmaceutical Overview
11.8.3 Hicin Pharmaceutical Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Hicin Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hicin Pharmaceutical Recent Developments
11.9 Huiyinbi Group
11.9.1 Huiyinbi Group Company Information
11.9.2 Huiyinbi Group Overview
11.9.3 Huiyinbi Group Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Huiyinbi Group Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Huiyinbi Group Recent Developments
11.10 Sino Pharma
11.10.1 Sino Pharma Company Information
11.10.2 Sino Pharma Overview
11.10.3 Sino Pharma Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Sino Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sino Pharma Recent Developments
11.11 Kinhoo Pharmaceutical
11.11.1 Kinhoo Pharmaceutical Company Information
11.11.2 Kinhoo Pharmaceutical Overview
11.11.3 Kinhoo Pharmaceutical Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Kinhoo Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Kinhoo Pharmaceutical Recent Developments
11.12 Salubris
11.12.1 Salubris Company Information
11.12.2 Salubris Overview
11.12.3 Salubris Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Salubris Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Salubris Recent Developments
11.13 Lancom
11.13.1 Lancom Company Information
11.13.2 Lancom Overview
11.13.3 Lancom Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Lancom Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Lancom Recent Developments
11.14 Lianhuan Group
11.14.1 Lianhuan Group Company Information
11.14.2 Lianhuan Group Overview
11.14.3 Lianhuan Group Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Lianhuan Group Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lianhuan Group Recent Developments
11.15 Northeast Pharmaceutical
11.15.1 Northeast Pharmaceutical Company Information
11.15.2 Northeast Pharmaceutical Overview
11.15.3 Northeast Pharmaceutical Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Northeast Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Northeast Pharmaceutical Recent Developments
11.16 Guangzhou Baiyunshan Pharma
11.16.1 Guangzhou Baiyunshan Pharma Company Information
11.16.2 Guangzhou Baiyunshan Pharma Overview
11.16.3 Guangzhou Baiyunshan Pharma Dapoxetine Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Guangzhou Baiyunshan Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Guangzhou Baiyunshan Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dapoxetine Industry Chain Analysis
12.2 Dapoxetine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dapoxetine Production Mode & Process
12.4 Dapoxetine Sales and Marketing
12.4.1 Dapoxetine Sales Channels
12.4.2 Dapoxetine Distributors
12.5 Dapoxetine Customers
13 Market Dynamics
13.1 Dapoxetine Industry Trends
13.2 Dapoxetine Market Drivers
13.3 Dapoxetine Market Challenges
13.4 Dapoxetine Market Restraints
14 Key Findings in The Global Dapoxetine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Johnson & Johnson
Menarini
Hetero Healthcare
Sun Pharmaceuticals
Emcure Pharmaceuticals
Kelun Pharmaceutical
HUaPont Pharma
Hicin Pharmaceutical
Huiyinbi Group
Sino Pharma
Kinhoo Pharmaceutical
Salubris
Lancom
Lianhuan Group
Northeast Pharmaceutical
Guangzhou Baiyunshan Pharma
听
听
*If Applicable.